IMAX vs ZD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IMAX presents a dichotomy between strong operational growth and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable financial health and the company shows impressive revenue growth (35.10%) and consistent earnings beats, the stock trades at a massive premium to its Graham Number ($9.42) and Intrinsic Value ($4.41). The bullish analyst sentiment and attractive PEG ratio (0.93) are heavily offset by aggressive insider selling and a bearish technical trend.
ZD presents a contradictory profile with a stable Piotroski F-Score of 4/9 but severe valuation discrepancies. While the stock has seen a strong 1-year recovery (+54.2%), it trades significantly above its Graham Number ($34.39) and far exceeds its growth-based intrinsic value ($8.05). The massive YoY earnings collapse (-99.70%) is a critical concern, though a low Forward P/E of 8.21 suggests analysts expect a sharp rebound. Overall, the company possesses strong gross margins but lacks the growth and technical momentum to justify a bullish rating at current levels.
Compare Another Pair
Related Comparisons
IMAX vs ZD: Head-to-Head Comparison
This page compares IMAX Corporation (IMAX) and Ziff Davis, Inc. (ZD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.